Skip to main content
. Author manuscript; available in PMC: 2020 Feb 11.
Published in final edited form as: Urology. 2018 Feb 2;114:133–138. doi: 10.1016/j.urology.2018.01.014

Table 3:

Kaplan Meier estimates (95% CI) for recurrence and cancer-specific mortality by histology type at orchiectomy and the difference. The difference was calculated as the Kaplan Meier estimate of those with EC subtracted from the estimate corresponding to those with other histology.

Recurrence
Time (years) Mixed Histology EC Difference
5 10% (8.5%, 13%) 3.1% (1.2%, 8.0%) 7.3% (3.7%, 11%)
10 12% (9.8%, 15%) 5.1% (1.9%, 13%) 7% (1.5%, 13%)
15 15% (12%, 20%) 5% (1.9%, 13%) 10% (4.0%, 16%)
20 15% (12%, 20%) 5% (1.9%, 13%) 10% (4.0%, 16%)
Cancer-Specific Mortality
Time (years) Mixed Histology EC Difference
5 4.6% (3.3%, 6.3%) 1.7% (0.4%, 6.8%) 2.9% (0.097%, 5.7%)
10 4.8% (3.5%, 6.6%) 1.7% (0.4%, 6.8%) 3.1% (0.26%, 5.9%)
15 5.2% (3.7%, 7.2%) 1.7% (0.4%, 6.8%) 3.5% (0.57%, 6.4%)
20 5.2% (3.7%, 7.2%) 1.7% (0.4%, 6.8%) 3.5% (0.57%, 6.4%)